Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat

References

• American Cancer Society. Cancer Facts and Figures 2006. American Cancer Society, Atlanta, GA, USA (2006).
   Google Scholar
• Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol. Biomarkers Prev.4(5), 567–571 (1995).
   PubMed Web of Science ®Google Scholar
• Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet337, 1197–1200 (1991).
   PubMed Web of Science ®Google Scholar
• Wu AH, Ziegler RG, Horn-Ross PL et al. Tofu and risk of breast cancer in Asian–Americans. Cancer Epidemiol. Biomarkers Prev.5, 901–906 (1996).
   PubMed Web of Science ®Google Scholar
• Ziegler RG, Hoover RN, Hildeshein RN et al. Migration patterns and breast cancer risk in Asian–American women. J. Natl Cancer Inst.85, 1819–1827 (1993).
   PubMed Web of Science ®Google Scholar
• Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the ‘French paradox’? Eur. J. Endocrinol.138, 619–620 (1998).
   PubMed Web of Science ®Google Scholar
• Boice JD, Monson RR. Breast cancer in women after repeated fluoroscopic examinations of the chest. J. Natl Cancer Inst.59, 823–832 (1977).
   PubMed Web of Science ®Google Scholar
• Land CE, McGregor DH. Breast cancer incidence among atomic bomb survivors: implications for radiobiologic risk at low doses. J. Natl Cancer Inst.62, 17–21 (1979).
   PubMedGoogle Scholar
• MacMahon B, Cole P, Brown J. Endocrinology and epidemiology of breast cancer. J. Natl Cancer Inst.50, 21–42 (1973).
   PubMedGoogle Scholar
• Russo J, Russo I. Biology of disease: biological and molecular bases of mammary carcinogenesis. Lab. Invest.57, 112–137 (1987).
   PubMed Web of Science ®Google Scholar
• Grubbs CJ, Hill DL, McDonough KC, Peckman JC. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells. J. Natl Cancer Inst.71, 625–628 (1983).
   Google Scholar
• Grubbs C J, Farnell DR, Hill DL, McDonough KC. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17β-estradiol and progesterone. J. Natl Cancer Inst.74, 927–931 (1985).
   PubMedGoogle Scholar
• Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology139, 4252–4263 (1998).
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann. Med.29, 95–120 (1997).
   PubMed Web of Science ®Google Scholar
• Sarkar FH, Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev.21, 265–280 (2002).
   PubMed Web of Science ®Google Scholar
• Barnes S, Lamartiniere CA. The role of phytoestrogens as cancer prevention agents. In: Cancer Chemoprevention, Volume 1. Kelloff GJ, Hawk ET, Sigman CC (Eds). Humana Press Inc., NJ, USA, 359–369 (2003).
   Google Scholar
• Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet342, 1209–1210 (1993).
   PubMed Web of Science ®Google Scholar
• Lamartiniere CA, Moore JB, Brown NM et al. Genistein suppresses mammary cancer in rats. Carcinogenesis16, 2833–2840 (1995).
   PubMed Web of Science ®Google Scholar
• Fritz WA, Coward L, Wang J, Lamartiniere CA. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis19(12), 2151–2158 (1998).
   PubMed Web of Science ®Google Scholar
• Lamartiniere CA. Timing of exposure and mammary cancer risk. J. Mammary Gland Biol. Neoplasia7(1), 67–76 (2002).
   PubMed Web of Science ®Google Scholar
• Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J. Nutr.132(3), 552S–558S (2002).
   PubMed Web of Science ®Google Scholar
• Hilakivi-Clarke L, Onojafe I, Raygada M et al. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer80, 1682–1688 (1999).
   PubMed Web of Science ®Google Scholar
• Badger TM, Ronis MJ, Hakkak R, Rowlands JC, Korourian S. The health consequences of early soy consumption. J. Nutr.132, 559S–565S (2002).
   PubMed Web of Science ®Google Scholar
• Lubet RL, Steele VE, Barnes S et al. Chemopreventive effects of genistein on methylnitrosourea (MNU)-induced mammary tumors. Proc. Am. Assoc. Cancer Res.41, 845 (2000).
   Google Scholar
• Anderson JJB, Anthony M, Messina M, Garner SC. Effects of phyto-oestrogens on tissues. Nutr. Res. Rev.12, 75–116 (1999).
   PubMed Web of Science ®Google Scholar
• Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res.61, 5045–5050 (2001).
   PubMed Web of Science ®Google Scholar
• Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr.131, 2957–2962 (2001).
   PubMed Web of Science ®Google Scholar
• Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res.58, 3833–3838 (1998).
   PubMed Web of Science ®Google Scholar
• Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer27, 271–275 (1996).
   Google Scholar
• Mizunuma H, Kanazawa K, Ogura S, Otsuka S, Nagai H. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer. Lab. Invest.62, 78–84 (2002).
   Google Scholar
• Jin ZM, MacDonald RS. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J. Nutr.132, 3186–3190 (2002).
   PubMed Web of Science ®Google Scholar
• Shu XO, Jin F, Dai Q et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev.10(5), 483–488 (2001).
   PubMed Web of Science ®Google Scholar
• Russo J, Russo IH. DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J. Natl Cancer Inst.61, 1451–1459 (1978).
   PubMed Web of Science ®Google Scholar
• Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res.7(3), 131–142 (2005).
   PubMed Web of Science ®Google Scholar
• Brown NM, Wang J, Cotroneo MS, Zhao YX, Lamartiniere CA. Prepubertal genistein treatment modulates TGF-α, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol. Cell. Endocrinol.144(1–2), 149–165 (1998).
   PubMedGoogle Scholar
• Dave B, Eason RR, Till SR et al. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis26(10), 1793–1803 (2005).
   PubMed Web of Science ®Google Scholar
• Cabanes A, Wang M, Olivo S et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis25(5), 741–748 (2004).
   PubMedGoogle Scholar
• Rowell C, Carpenter DM, Lamartiniere CA. Chemoprevention of breast cancer, proteomic discovery of genistein action in the rat mammary gland. J. Nutr.135(12 Suppl.), 2953S–2959S (2005).
   PubMed Web of Science ®Google Scholar
• Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C. Resveratrol and breast cancer risk. J. Cancer Prevention14, 139–142 (2005).
   PubMed Web of Science ®Google Scholar
• Bhat K, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann. NY Acad. Sci.957, 210–229 (2002).
   PubMed Web of Science ®Google Scholar
• Le Corre L, Chalabi N, Delort L, Bignon Y-J, Bernard-Gallon DJ. Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol. Nutr. Food Res.49, 462–471 (2005).
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science275(5297), 218–220 (1997).
   PubMed Web of Science ®Google Scholar
• Bhat KP, Lantvit D, Christov K, Mehta RJ, Moon RC, Pezzuto JM. Estrogenic and antiestrogenic properties of resveratrol in mammary cancer models. Cancer Res.61, 7456–7463 (2001).
   PubMed Web of Science ®Google Scholar
• Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res.62, 4945–4954 (2002).
   PubMed Web of Science ®Google Scholar
• Provinciali M, Re F, Donnini A et al. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int. J. Cancer115(1), 36–45 (2005).
   PubMedGoogle Scholar
• Whitsett TG, Carpenter DM, Lamartiniere CA. Resveratrol, but not EGCG, in the diet can suppress DMBA-induced mammary cancer in rats. Carcinogenesis5(1), 15 (2006).
   Google Scholar
• Zhou J-R, Yu L, Mai Z, Blackburn GL. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int. J. Cancer108, 8–14 (2004).
   PubMed Web of Science ®Google Scholar